# Silo Pharma, Inc.: Form 8-K, filed Jun 27, 2024

- Company: [Silo Pharma, Inc.](/companies/silo.md) (CIK 1514183)
- Form: 8-K
- Filed: 2024-06-27
- Accepted by EDGAR: Jun 27, 2024, 16:23 ET
- Period: 2024-06-26
- Accession: 0001213900-24-056678
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1514183/000121390024056678/ea0208662-8k_silo.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1514183/000121390024056678/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1514183/000121390024056678/ea0208662-8k_silo.htm

Filed Jun 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-056678. Last ingested by Listed: Nov 14, 2026, 21:25 ET. No prices; not investment advice.
